COVID-19 infection after autologous stem cell transplantation for systemic sclerosis

Ann Rheum Dis. 2023 Jul;82(7):996-998. doi: 10.1136/ard-2023-223915. Epub 2023 Mar 8.

¹ Centre for Interdisciplinary Clinical Immunology, Rheumatology and Auto-inflammatory Diseases and Department of Internal Medicine II (Hematology, Oncology, Rheumatology and Clinical Immunology), University Hospital Tubingen, Tuebingen, Germany joerg.henes@med.uni-tuebingen.de.
² Department of Internal Medicine II (Hematology, Oncology, Rheumatology and Clinical Immunology), University Hospital Tubingen, Tuebingen, Germany.
³ Centre for Interdisciplinary Clinical Immunology, Rheumatology and Auto-inflammatory Diseases and Department of Internal Medicine II (Hematology, Oncology, Rheumatology and Clinical Immunology), University Hospital Tubingen, Tuebingen, Germany.

No abstract available

Keywords: Covid-19; Infections; Scleroderma, Systemic; Vaccination.

Publication types